drugset / Trial / NCT00387647
Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy
Phase 2
Completed
24 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if patients older than 60, with acute myeloid leukemia, who are in complete remission following initial chemotherapy, will live longer and have a lower rate of leukemia relapse when treated with azacitidine.
Timeline
- Start
- 2006-08
- Primary completion
- 2013-10
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 50 mg/m2 | Subcutaneous |